Human Embryonic Stem Cells in Treatment of Spinal Cord Injury: A Prospective Study

Geeta Shroff, Puneet Agarwal, Avinash Mishra, Nayan Sonowal

Abstract


Background: Spinal cord injury (SCI) is a devastating disease which impacts the patient physically, psychologically and financially. Although the pharmacological and non-pharmacological methods are used, none of them are able to improve the quality of life permanently. Recent advancement in the regenerative medicines has risen a new dawn for treatment of SCI.

Method: In the current study, human embryonic stem cells (hESCs) were used on pre-diagnosed chronic SCI patients with informed written and video consent. The cell lines were cultured and maintained in a good manufacturing practice (GMP), good laboratory practice (GLP), and good tissue practice (GTP) compliance laboratory which were free of animal product and chromosomally stable. The patients were scored according to the American Spinal Injury Association (ASIA) scale. There were four treatment phases (T1, T2, T3 and T4) with gap phases. Patient received 0.25 mL of hESCs through intramuscular (IM) route twice daily, 1 mL of hESCs every 10 days through intravenous (IV) route and 1 - 5 mL of hESCs for 5 - 7 days through supplemental routes. Magnetic resonance imaging (MRI) tractography was performed for all the patients before and after the therapy.

Result: Of 11 patients at the beginning of therapy, seven patients were on ASIA score A, one patient was on ASIA score B, two patients were on ASIA score C and one patient was on ASIA score D. At the end of treatment, three patients moved to lower scale, i.e. ASIA score D, two patients to ASIA score C and rest all the patients were on ASIA score A. There was a remarkable improvement in the signs and symptoms of patients clinically. No adverse event and teratoma formation was observed.

Conclusion: hESC therapy showed remarkable improvement in the clinical symptoms in SCI patients.




J Neurol Res. 2015;5(3):213-220
doi: http://dx.doi.org/10.14740/jnr339w

 


Keywords


Spinal cord injury; Human embryonic stem cells; ASIA score; Prospective study

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Neurology Research, bimonthly, ISSN 1923-2845 (print), 1923-2853 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.neurores.org   editorial contact: editor@neurores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.